Feinstein Institute for Medical Research: Bioelectronic Medicine Shows Promise to Treat Shock From Extreme Blood Loss
October 25, 2019
October 25, 2019
MANHASSET, New York, Oct. 25 -- Feinstein Institute for Medical Research issued the following news release:
* * *
- Hemorrhagic shock accounts for 40 percent of trauma deaths
* * *
Feinstein Institutes for Medical Research scientists published a review of a bioelectronic medicine strategy to treat hemorrhagic shock (HS) in the Springer Nature journal, Bioelectronic Medicine.
HS occurs when the body's cardiovascular system begins to . . .
* * *
- Hemorrhagic shock accounts for 40 percent of trauma deaths
* * *
Feinstein Institutes for Medical Research scientists published a review of a bioelectronic medicine strategy to treat hemorrhagic shock (HS) in the Springer Nature journal, Bioelectronic Medicine.
HS occurs when the body's cardiovascular system begins to . . .